Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,584 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Alzheimer's drug-development pipeline: 2016.
Cummings J, Morstorf T, Lee G. Cummings J, et al. Alzheimers Dement (N Y). 2016 Aug 17;2(4):222-232. doi: 10.1016/j.trci.2016.07.001. eCollection 2016 Nov. Alzheimers Dement (N Y). 2016. PMID: 29067309 Free PMC article.
Alzheimer's disease drug development pipeline: 2017.
Cummings J, Lee G, Mortsdorf T, Ritter A, Zhong K. Cummings J, et al. Alzheimers Dement (N Y). 2017 May 24;3(3):367-384. doi: 10.1016/j.trci.2017.05.002. eCollection 2017 Sep. Alzheimers Dement (N Y). 2017. PMID: 29067343 Free PMC article. Review.
Randomized, controlled, proof-of-concept trial of MK-7622 in Alzheimer's disease.
Voss T, Li J, Cummings J, Farlow M, Assaid C, Froman S, Leibensperger H, Snow-Adami L, McMahon KB, Egan M, Michelson D. Voss T, et al. Among authors: cummings j. Alzheimers Dement (N Y). 2018 Apr 26;4:173-181. doi: 10.1016/j.trci.2018.03.004. eCollection 2018. Alzheimers Dement (N Y). 2018. PMID: 29955661 Free PMC article.
Alzheimer's disease drug development pipeline: 2018.
Cummings J, Lee G, Ritter A, Zhong K. Cummings J, et al. Alzheimers Dement (N Y). 2018 May 3;4:195-214. doi: 10.1016/j.trci.2018.03.009. eCollection 2018. Alzheimers Dement (N Y). 2018. PMID: 29955663 Free PMC article.
Neuroscience learning from longitudinal cohort studies of Alzheimer's disease: Lessons for disease-modifying drug programs and an introduction to the Center for Neurodegeneration and Translational Neuroscience.
Miller JB, Cummings J, Nance C, Ritter A. Miller JB, et al. Among authors: cummings j. Alzheimers Dement (N Y). 2018 Jul 11;4:350-356. doi: 10.1016/j.trci.2018.06.006. eCollection 2018. Alzheimers Dement (N Y). 2018. PMID: 30175229 Free PMC article. Review.
A 24-week double-blind placebo-controlled study of the efficacy and safety of the AMPA modulator S47445 in patients with mild to moderate Alzheimer's disease and depressive symptoms.
Bernard K, Gouttefangeas S, Bretin S, Galtier S, Robert P, Holthoff-Detto V, Cummings J, Pueyo M. Bernard K, et al. Among authors: cummings j. Alzheimers Dement (N Y). 2019 Jun 24;5:231-240. doi: 10.1016/j.trci.2019.04.002. eCollection 2019. Alzheimers Dement (N Y). 2019. PMID: 31297437 Free PMC article.
2,584 results